TUBA4A antibody targets the protein TUBA4A, a member of the α-tubulin family, which is crucial for microtubule formation. Microtubules are dynamic cytoskeletal structures involved in cell division, intracellular transport, and maintenance of cell shape. TUBA4A, encoded by the *TUBA4A* gene, plays a key role in regulating microtubule stability and dynamics through interactions with other tubulin isoforms and microtubule-associated proteins (MAPs).
Antibodies against TUBA4A are widely used in research to study microtubule organization, cell cycle progression, and cytoskeletal abnormalities. They are applied in techniques like Western blotting, immunofluorescence, and immunohistochemistry to visualize TUBA4A expression and localization in cells or tissues.
Mutations in *TUBA4A* are linked to neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), and cancer, where disrupted microtubule function may contribute to disease mechanisms. TUBA4A antibodies help investigate these associations, enabling researchers to explore how altered tubulin expression or post-translational modifications impact cellular processes. Additionally, these antibodies aid in characterizing model organisms or cell lines with engineered *TUBA4A* mutations.
Commercial TUBA4A antibodies are typically validated for specificity and sensitivity, though variability may exist depending on epitope regions and experimental conditions. Their utility spans basic cell biology, disease mechanism studies, and potential diagnostic applications in pathological conditions involving cytoskeletal dysfunction.